220 related articles for article (PubMed ID: 31090018)
1. A Long-Term Cost-Effectiveness Analysis Comparing Radiofrequency Catheter Ablation with Antiarrhythmic Drugs in Treatment of Chinese Patients with Atrial Fibrillation.
Du X; He X; Jia Y; Wu J; Long D; Yu R; Sang C; Yin H; Xuan J; Dong J; Ma C
Am J Cardiovasc Drugs; 2019 Dec; 19(6):569-577. PubMed ID: 31090018
[TBL] [Abstract][Full Text] [Related]
2. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency Catheter Ablation Versus Cryoballoon Ablation in the Treatment of Paroxysmal Atrial Fibrillation: A Cost-effectiveness Analysis in China.
Sun XR; He SN; Lin ZY; Zhang L; Wang YJ; Zeng LJ; Shi L; Xuan JW; Tian Y; Yang XC; Liu XP
Clin Ther; 2019 Jan; 41(1):78-91. PubMed ID: 30559005
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.
Aronsson M; Walfridsson H; Janzon M; Walfridsson U; Nielsen JC; Hansen PS; Johannessen A; Raatikainen P; Hindricks G; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Levin LÅ
Europace; 2015 Jan; 17(1):48-55. PubMed ID: 25341739
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation using the ThermoCool SmartTouch Catheter guided by ablation index versus antiarrhythmic drugs in atrial fibrillation treatment in China: a cost-consequence analysis.
Zhang B; Han J; Zhou D; Jiang J; Zhong J; Lu Y; Zuo C; Lu X; Xuan J; Zu A; He Y; Sun X; Chen L; Zheng L
J Comp Eff Res; 2024 Feb; 13(2):e230035. PubMed ID: 38205729
[No Abstract] [Full Text] [Related]
6. Cost-Effectiveness of Cryoballoon Ablation Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation in China: Results Based on Real-World Data.
Ming J; Wei Y; Sun H; Wong G; Yang G; Pong R; Chen Y
Value Health; 2019 Aug; 22(8):863-870. PubMed ID: 31426926
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Cost-Effectiveness Comparison of Catheter Ablation and Antiarrhythmic Drugs in Atrial Fibrillation Treatment Using Discrete Event Simulation.
Hu M; Han Y; Zhao W; Chen W
Value Health; 2022 Jun; 25(6):975-983. PubMed ID: 35667785
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom.
McKenna C; Palmer S; Rodgers M; Chambers D; Hawkins N; Golder S; Van Hout S; Pepper C; Todd D; Woolacott N
Heart; 2009 Apr; 95(7):542-9. PubMed ID: 19095714
[TBL] [Abstract][Full Text] [Related]
10. Economic and Health Value of Delaying Atrial Fibrillation Progression Using Radiofrequency Catheter Ablation.
Berman AE; Kabiri M; Wei T; Galvain T; Sha Q; Kuck KH
Circ Arrhythm Electrophysiol; 2023 Apr; 16(4):e011237. PubMed ID: 36891899
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of the convergent procedure and catheter ablation for non-paroxysmal atrial fibrillation.
Anderson LH; Black EJ; Civello KC; Martinson MS; Kress DC
J Med Econ; 2014 Jul; 17(7):481-91. PubMed ID: 24693987
[TBL] [Abstract][Full Text] [Related]
12. Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction.
Chew DS; Loring Z; Anand J; Fudim M; Lowenstern A; Rymer JA; Weimer KED; Atwater BD; DeVore AD; Exner DV; Noseworthy PA; Yancy CW; Mark DB; Piccini JP
Circ Cardiovasc Qual Outcomes; 2020 Dec; 13(12):e007094. PubMed ID: 33280436
[TBL] [Abstract][Full Text] [Related]
13. Left atrial emptying fraction predicts recurrence of atrial fibrillation after radiofrequency catheter ablation.
Chou CC; Lee HL; Chang PC; Wo HT; Wen MS; Yeh SJ; Lin FC; Hwang YT
PLoS One; 2018; 13(1):e0191196. PubMed ID: 29364912
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of focal impulse and rotor modulation guided ablation added to pulmonary vein isolation for atrial fibrillation.
Baykaner T; Duff S; Hasegawa JT; Mafilios MS; Turakhia MP
J Cardiovasc Electrophysiol; 2018 Apr; 29(4):526-536. PubMed ID: 29436112
[TBL] [Abstract][Full Text] [Related]
15. Cost-Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation.
Lau D; Sandhu RK; Andrade JG; Ezekowitz J; So H; Klarenbach S
J Am Heart Assoc; 2021 Jul; 10(14):e019599. PubMed ID: 34238020
[TBL] [Abstract][Full Text] [Related]
16. The Cost-Effectiveness of First-Line Cryoablation vs First-Line Antiarrhythmic Drugs in Canadian Patients With Paroxysmal Atrial Fibrillation.
Andrade JG; Moss JWE; Kuniss M; Sadri H; Wazni O; Sale A; Ismyrloglou E; Chierchia GB; Kaplon R; Mealing S; Bainbridge J; Bromilow T; Lane E; Khaykin Y
Can J Cardiol; 2024 Apr; 40(4):576-584. PubMed ID: 38007219
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English National Health Service perspective.
Paisey J; Moss J; Andrade J; Kuniss M; Wazni O; Chierchia GB; Mealing S; Ismyrloglou E; Sale A; Souter M; Kaplon R; Bromilow T; Lane E; Lewis D; Todd D
Open Heart; 2024 Jan; 11(1):. PubMed ID: 38238026
[TBL] [Abstract][Full Text] [Related]
18. Modelling the lifetime cost-effectiveness of catheter ablation for atrial fibrillation with heart failure.
Gao L; Moodie M
BMJ Open; 2019 Sep; 9(9):e031033. PubMed ID: 31492790
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes and Improvements in Quality of Life in Patients with Atrial Fibrillation Treated with Catheter Ablation vs. Antiarrhythmic Drugs.
Zheng ZH; Fan J; Ji CC; Cheng YJ; Chen XM; Jiang JZ; Wu SH
Am J Cardiovasc Drugs; 2021 May; 21(3):299-320. PubMed ID: 33000397
[TBL] [Abstract][Full Text] [Related]
20. [Cost-benefit analysis of concomitant atrial fibrillation management in Spain].
López Gude MJ; Rodríguez Bezos D; Rodríguez Barrios JM
Gac Sanit; 2010; 24(1):59-65. PubMed ID: 19931216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
